Some companies cut corners, use questionable sources for ingredients, or operate without proper oversight
Here is a clear summary of what the Phase 2 data reported
Clinical trials have shown that GLP-1 medications can help patients lose weight and better control blood sugar, potentially reducing the risk of heart attacks, strokes and other serious health complications
Most qualified physicians who possess a successful background treating patients with peptides, in particular, might charge higher rates for this service
Ziegenfuss, T., Landis, J., & Hofheins, J
Much more interesting chart (except for investors)